Novo Nordisks new pricing strategy, announced in March before the patent expiration, offers the initial dose of the Wegovy weight loss pen, 0.25 milligrams (mg), for free with a prescription that includes the final indicated dose
- Provided for general business use and should be reviewed/approved for your clinics specific requirements and local regulations
Excitingly, clinical trials have proven that empagliflozin significantly reduces the relative risk of hospitalization for heart failure and cardiovascular death in T2DM patients with cardiovascular disease
Our expert medical team reviews your weight loss progress, facial anatomy, and goals to design a fully tailored plan
Subjects in both the study and placebo groups also received behavioral lifestyle therapy focusing on healthy diet and exercise
While blindness is considered a rare potential symptom of Ozempic, initial findings show a significant connection